Matthew Shair, Director at Nuvalent, Inc. (NUVL), sold 78,895 shares at $76.74 ($6.1M) on 2024-03-25, disclosed to the SEC on 2024-03-27.
Scheduled sale ($6.1M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $76.74 | 1,895 | $145K | 2.4% |
| 2 | $76.74 | 35,545 | $2.7M | 45.0% |
| 3 | $76.74 | 35,545 | $2.7M | 45.0% |
| 4 | $76.74 | 1,895 | $145K | 2.4% |
| 5 | $77.37 | 1,955 | $151K | 2.5% |
| 6 | $77.37 | 105 |
| $8K |
| 0.1% |
| 7 | $77.37 | 1,955 | $151K | 2.5% |
| Total | $76.77 avg | 78,895 | $6.1M | 100% |
| Filing → |
| NUVL | SELL | 2025-02-25 | $265K | — | Filing → |
| NUVL | SELL | 2025-01-29 | $302K | — | Filing → |
| NUVL | SELL | 2024-12-26 | $285K | — | Filing → |